Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OncoAlert and ecancer weekly roundup for November 15 - 21, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Nov 2020

OncoAlert and ecancer weekly roundup for November 8 - 14, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Nov 2020

OncoAlert and ecancer weekly roundup for November 2 - 7, 2020

Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020

SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer

Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020

PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer

Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020

Sotorasib for advanced non-small cell lung cancer

Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020

VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

The ENA virtual meeting 2020

Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020

Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation

Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020

Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy

Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020

OncoAlert and ecancer weekly roundup for October 26 - 31, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
2 Nov 2020